This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Jehad Charo: Innovator in DNA Vaccination
Introduction
Jehad Charo is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of DNA vaccination. His innovative approach aims to enhance immune responses against various diseases.
Latest Patents
Charo holds a patent for a method of DNA vaccination. This method involves vaccinating a mammal against a disease state by administering a nucleotide sequence encoding an antigenic peptide associated with the disease. Additionally, it includes administering a compound that enhances both humoral and cellular immune responses initiated by the antigenic peptide. The preferred compound in this method is Tucaresol or a physiologically acceptable salt or ester thereof.
Career Highlights
Jehad Charo is associated with SmithKline Beecham Corporation, where he has been involved in groundbreaking research and development. His work has contributed to advancements in vaccine technology, which is crucial for public health.
Collaborations
Charo collaborates with Rolf Kiessling, a fellow researcher, to further explore the potential of DNA vaccination and its applications in medicine.
Conclusion
Jehad Charo's innovative work in DNA vaccination represents a significant advancement in the field of immunology. His contributions are paving the way for new therapeutic strategies against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile